Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

952.74 -1.43 (-0.15%)
Official Closing Price Updated: 7:00 PM EDT, Aug 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,063,315
Open 955.44
Bid (Size) 949.75 (2)
Ask (Size) 952.00 (9)
Prev. Close 954.17
Today's Range 943.11 - 960.50
52wk Range 516.57 - 972.53
Shares Outstanding N/A
Dividend Yield 0.47%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Mounjaro Scores Yet Another Win: Why Eli Lilly Is Still a Buy
The drugmaker looks unstoppable. 
Via The Motley Fool
If You Like Eli Lilly, Then You'll Love This Little-Known Specialty Manufacturing Stock
Jacobs Solutions stands to be a beneficiary of the red-hot weight loss movement fueling the pharmaceutical market. 
Via The Motley Fool

Performance

YTD
+60.88%
+60.88%
1 Month
+16.02%
+16.02%
3 Month
+17.93%
+17.93%
6 Month
+23.42%
+23.42%
1 Year
+72.08%
+72.08%

More News

Read More
Prediction: These Will Be the Best-Performing S&P 500 Stocks of 2024
Via The Motley Fool
Topics Stocks
Exposures US Equities
AskSlim Market Week - Friday, Aug. 23
Via Talk Markets
Why Apple Stock And This 'Recession-Proof' Leader Strengthen Market's Bull Case
Via Investor's Business Daily
Exploring The Competitive Space: Eli Lilly Versus Industry Peers In Pharmaceuticals
Via Benzinga
Check Out What Whales Are Doing With LLY
Via Benzinga
Stock Market Rallies As Powell Confirms Rate Cuts; Palo Alto, Cava, Target Jump: Weekly Review
Via Investor's Business Daily
The Stock Market Isn't Rocking This Month But The S&P 500 Is Headed For Its Best August In 3 Years
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Visualizing The World’s Top 25 Companies By Market Cap
Via Talk Markets
RedHill's Opaganib Shows Diabetes And Obesity Potential With Positive In Vivo Results
Via News Direct
These Were the Top-Selling GLP-1 Drugs Last Quarter From Eli Lilly and Novo Nordisk
Via The Motley Fool
Eli Lilly Hits All-Time High, Gets Watchlist Trifecta: These Names Just Added To IBD 50, Other Top Stock Screens
Via Investor's Business Daily
Eli Lilly's Growth Rate Is Fantastic, but This Number Is Even Better
Via The Motley Fool
This Undervalued Stock Could Join the Race With Eli Lilly to the $1 Trillion Club
Via The Motley Fool
Wegovy Now Available Through Sesame's $249 Monthly Compounded Program Despite Supply Shortages
Via Benzinga
Novo Nordisk Vs. Eli Lilly: Beyond The Weight-Loss Drug Battle
Via Benzinga
Topics Economy
Exposures Supply Chain
Asia Mixed, European Markets Advance; Gold Stays Near All Time High While Dollar Gains - Global Markets Today While US Slept
Via Benzinga
Eli Lilly Stock Could Soar to $1,150, According to a Wall Street Analyst. Is It a Buy at Around $945?
Via The Motley Fool
Why Eli Lilly Topped the Market on Tuesday
Via The Motley Fool
Biotech Bull Market: 3 Ways To Play It
Via Talk Markets
Topics Economy
Exposures Interest Rates
Wall Street Eases, Bonds Rises, US Dollar Falls To 8-Month Low: What's Driving Markets Tuesday?
Via Benzinga
Fabrinet Posts Strong Earnings, Joins Amer Sports, Hawaiian Holdings And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Eli Lilly, An IBD 50 Stock, Nears Record High On Another Weight-Loss Win
Via Investor's Business Daily
Merck's Stock Dip Offers a Buying Opportunity: Here’s Why
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.